BRIEF published on 01/20/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Notification Share Acquisition Atlas Special Opportunities Oxurion Retinal Disease Therapies
BRIEF published on 01/20/2025 at 18:05, 1 year 1 month ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Acquisition D'actions Oxurion Opportunités Spéciales Atlas Avis De Transparence Thérapies Pour Les Maladies De La Rétine
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities, LLC, crossing the 20% threshold. Company engaged in developing ophthalmic therapies Transparency Notification Ophthalmic Therapies Oxurion NV Shares Ownership Belgian Transparency Legislation
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC over aankoop aandelen, voldoet aan Belgische transparantiewetgeving. Oogheelkundig bedrijf gevestigd in Leuven, België Transparantiekennisgeving Oxurion NV Biofarmaceutisch Netvliesaandoeningen Belgische Transparantiewetgeving
BRIEF published on 01/14/2025 at 18:05, 1 year 1 month ago Oxurion reçoit une mise à jour de transparence d'Atlas Special Opportunities LLC Actions Atlas Transparence Biopharmaceutique Oxurion
BRIEF published on 01/14/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Update from Atlas Special Opportunities LLC Actions Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 1 month ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC wegens verkoop van aandelen. Leuven biofarmaceutisch bedrijf actief in oftalmologische therapieën Transparantiekennisgeving Oxurion NV Biofarmaceutisch Oftalmologische Therapieën België
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 1 month ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC Oxurion NV announces receiving an amended transparency notification regarding share ownership by Atlas Special Opportunities, LLC, crossing under the 3% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Retinal Disease
BRIEF published on 01/13/2025 at 18:05, 1 year 1 month ago Oxurion Updates Voting Rights Following Convertible Bond Conversion Voting Rights Convertible Bonds Capital Increase Market Opportunities Oxurion
BRIEF published on 01/13/2025 at 18:05, 1 year 1 month ago Oxurion met à jour ses droits de vote suite à la conversion des obligations convertibles Obligations Convertibles Augmentation De Capital Droit De Vote Opportunités De Marché Oxurion
Published on 02/28/2026 at 10:00, 23 hours 49 minutes ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 00:10, 1 day 9 hours ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 21:50, 11 hours 59 minutes ago CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF "YOU'LL NEVER WALK ALONE"
Published on 02/28/2026 at 21:20, 12 hours 29 minutes ago Huawei's SuperPoD Portfolio Creates New Option for Global Computing at MWC Barcelona 2026
Published on 02/28/2026 at 21:00, 12 hours 49 minutes ago CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'
Published on 02/28/2026 at 19:15, 14 hours 34 minutes ago Athletes from Sweden and the Netherlands Win Medals at the Olympic Winter Games Milano Cortina 2026 as Team TCL Ambassador Reaches the Podium
Published on 02/28/2026 at 16:55, 16 hours 54 minutes ago CGTN: How China's path of democracy safeguards people's rights and interests
Published on 02/27/2026 at 23:00, 1 day 10 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 23:00, 1 day 10 hours ago Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 15 hours ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 18:02, 1 day 15 hours ago AXA: Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA
